- Home
- Supplements
- Apigenin
- Stress Resilience
Apigenin for Stress Resilience
Any calming effect is likely small and comes from chamomile preparations rather than isolated apigenin.
Overview
Verdict
How It Works
Dosing & Protocol
Typical dose
- Recommended dose
- No validated dose - apigenin alone is untested
- Expected timeframe
- Not established
Protocol
- studied dose
- Chamomile extract 500-1500 mg/day in generalised anxiety disorder
- evidence note
- Verdict is insufficient - the trial evidence is for chamomile extract, not apigenin
- what happened
- Modest symptom reduction was seen, but the active constituents were never isolated and apigenin alone has not been tested
- better first choices
- Ashwagandha root extract has direct randomised stress and cortisol data
- if you still trial it
- Use a standardised chamomile extract, measure Perceived Stress Scale at baseline and week 4, and stop if unchanged
Evidence
What the studies say
Long-term chamomile (Matricaria chamomilla L.) treatment for generalized anxiety disorder: a randomized clinical trial
Mao JJ, Xie SX, Keefe JR +3 more
Long-term chamomile (Matricaria chamomilla L.) treatment for generalized anxiety disorder: a randomized clinical trial.
Safety
Caveats
Asteraceae allergy risk. Additive sedation with anxiolytics and alcohol; additive bleeding risk with warfarin. CYP inhibition may raise levels of other medications. Avoid in pregnancy.
Less likely to help if
Medical Disclaimer
The information provided on this website is for educational and informational purposes only and is not intended as a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified health provider with any questions you may have regarding a medical condition or before starting any supplement regimen.
Individual results may vary. The statements on this website have not been evaluated by the Food and Drug Administration. Products and information are not intended to diagnose, treat, cure, or prevent any disease.